Home >> Healthcare >> Small Nucleic Acid Therapies Market

Global Small Nucleic Acid Therapies Market Size,Trends, Growth Forecast to 2031

Category : Healthcare | Report Code : 928 | Pages : 141 | Oct 2024

Report Overview

Small Nucleic Acid Therapies are a class of pharmaceuticals designed to treat various diseases by targeting specific genes or genetic processes within the human body. They are distinct from traditional small molecule drugs and instead rely on nucleic acids, which are the building blocks of genetic information. Nucleic acid drugs encompass  various types of pharmaceuticals that use nucleic acids, such as DNA or RNA,   as their active components to target specific genes or genetic processes.

The global Small Nucleic Acid Therapies market size is projected to grow from US$ 12670 million in 2024 to US$ 15900 million in 2030; it is expected to grow at a CAGR of 3.9% from 2024 to 2030.

Analytic Insights Hub' newest research report, the “Small Nucleic Acid Therapies Industry Forecast” looks at past sales and reviews total world Small Nucleic Acid Therapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Small Nucleic Acid Therapies sales for 2023 through 2029. With Small Nucleic Acid Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Nucleic Acid Therapies industry.

This Insight Report provides a comprehensive analysis of the global Small Nucleic Acid Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Nucleic Acid Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Nucleic Acid Therapies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Nucleic Acid Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Nucleic Acid Therapies.

United States market for Small Nucleic Acid Therapies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Small Nucleic Acid Therapies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Small Nucleic Acid Therapies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Small Nucleic Acid Therapies players cover Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Small Nucleic Acid Therapies market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Antisense Oligonucleotides (ASO)
    siRNA
    mRNA

Segmentation by Application:
    Neuromuscular Diseases
    hATTR
    COVID-19
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Antisense Oligonucleotides (ASO)
    siRNA
    mRNA

Segmentation by Application:
    Neuromuscular Diseases
    hATTR
    COVID-19
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Sarepta Therapeutics
    Ionis Pharmaceuticals
    Alnylam
    Biogen
    Nippon Shinyaku
    Sobi
    Novartis
    BioNTech
    Pfizer
    Moderna Therapeutics
    Jazz Pharmaceuticals
    CureVac
    Regulus Therapeutics
    ProQR
    Secarna
    MiNA Therapeutics
    Sylentis
    Arrowhead
    Silence Therapeutics
    Dicerna

Frequently Asked Questions?

Ans - The purpose of a Small Nucleic Acid Therapies market research report is to provide data-driven insights and analysis on a Small Nucleic Acid Therapies market. It helps businesses understand industry trends, competition, consumer behavior, market size, growth potential, and risks, supporting strategic decision-making.

Ans - Market research reports typically include both quantitative (market size, revenue, growth rates) and qualitative (trends, consumer preferences, competitive analysis) data. It often includes industry statistics, surveys, expert opinions, historical data, and future forecasts.

Ans - The forecast period typically for Small Nucleic Acid Therapies market report spans the next 5 to 10 years. It includes projected market trends, growth opportunities, and potential challenges.

Ans - Yes, Analytic Insights Hub customization services, allowing businesses to focus on specific geographies, sectors, or market segments that are relevant to them.

Ans - The report highlights major trends such as technological innovations, consumer behavior shifts, regulatory changes, or emerging markets that may impact the industry?s growth.